dimethyl sulfoxide has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mi, X | 1 |
| Ni, C | 1 |
| Zhao, J | 1 |
| Amin, N | 1 |
| Jiao, D | 1 |
| Fang, M | 1 |
| Ye, X | 1 |
1 other study available for dimethyl sulfoxide and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
P2Y12 receptor mediates apoptosis and demyelination to affect functional recovery in mice with spinal cord injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Calbindins; Demyelinating Diseases; Dimethyl Sulfoxi | 2023 |